» Articles » PMID: 32397415

Histidyl-Proline Diketopiperazine Isomers As Multipotent Anti-Alzheimer Drug Candidates

Overview
Journal Biomolecules
Publisher MDPI
Date 2020 May 14
PMID 32397415
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Cyclic dipeptides administered by both parenteral and oral routes are suggested as promising candidates for the treatment of neurodegeneration-related pathologies. In this study, we tested Cyclo (His-Pro) isomers (cHP1-4) for their anti-Alzheimer potential using a differentiated human neuroblastoma cell line (SH-SY5Y) as an Alzheimer's disease (AD) experimental model. The SH-SY5Y cell line was differentiated by the application of retinoic acid (RA) to obtain mature neuron-like cells. Amyloid-beta 1-42 () peptides, the main effector in AD, were administered to the differentiated cell cultures to constitute the in vitro disease model. Next, we performed cell viability analyses 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and lactate dehydrogenase (LDH) release assays) to investigate the neuroprotective concentrations of cyclodipeptides using the in vitro AD model. We evaluated acetylcholinesterase (AChE), α- and β-secretase activities (TACE and BACE1), antioxidant potency, and apoptotic/necrotic properties and performed global gene expression analysis to understand the main mechanism behind the neuroprotective features of cHP1-4. Moreover, we conducted sister chromatid exchange (SCE), micronucleus (MN), and 8-hydroxy-2'-deoxyguanosine (8-OHdG) analyses to evaluate the genotoxic damage potential after applications with cHP1-4 on cultured human lymphocytes. Our results revealed that cHP1-4 isomers provide a different degree of neuroprotection against -induced cell death on the in vitro AD model. The applications with cHP1-4 isomers altered the activity of AChE but not the activity of TACE and BACE1. Our analysis indicated that the cHP1-4 increased the total antioxidant capacity without altering total oxidative status levels in the cellular AD model and that cHP1-4 modulated the alterations of gene expressions by exposure. We also observed that cHP1-4 exhibited noncytotoxic and non-genotoxic features in cultured human whole blood cells. In conclusion, cHP1-4 isomers, especially cHP4, have been explored as novel promising therapeutics against AD.

Citing Articles

Natural and engineered cyclodipeptides: Biosynthesis, chemical diversity, and engineering strategies for diversification and high-yield bioproduction.

Widodo W, Billerbeck S Eng Microbiol. 2024; 3(1):100067.

PMID: 39628525 PMC: 11610984. DOI: 10.1016/j.engmic.2022.100067.


Exploring the Frontier of Cyclic Dipeptides: A Bioinformatics Approach to Potential Therapeutic Applications in Schizophrenia.

Li X, Nong X, Yang J, Li M, Wang Q, Sun M Int J Mol Sci. 2024; 25(21).

PMID: 39518975 PMC: 11546255. DOI: 10.3390/ijms252111421.


Cyclodipeptide oxidase is an enzyme filament.

Andreas M, Giessen T Nat Commun. 2024; 15(1):3574.

PMID: 38678027 PMC: 11055893. DOI: 10.1038/s41467-024-48030-9.


Novel styryl-thiazole hybrids as potential anti-Alzheimer's agents.

Gouleni N, Di Rienzo A, Yilmaz A, Selvitopi H, Arslan M, Mardinoglu A RSC Med Chem. 2023; 14(11):2315-2326.

PMID: 38020070 PMC: 10650344. DOI: 10.1039/d3md00308f.


Toxicity of Glycyl-l-Prolyl-l-Glutamate Pseudotripeptides: Cytotoxic, Oxidative, Genotoxic, and Embryotoxic Perspectives.

Turkez H, Tozlu O, Tatar A, Arslan M, Cadirci K, Marinelli L J Toxicol. 2022; 2022:3775194.

PMID: 36444193 PMC: 9701129. DOI: 10.1155/2022/3775194.


References
1.
Grottelli S, Ferrari I, Pietrini G, Peirce M, Minelli A, Bellezza I . The Role of Cyclo(His-Pro) in Neurodegeneration. Int J Mol Sci. 2016; 17(8). PMC: 5000729. DOI: 10.3390/ijms17081332. View

2.
Priest R, Spaull J, Buckton J, Grimley R, Sims M, Binks M . Immunomodulatory activity of a methionine aminopeptidase-2 inhibitor on B cell differentiation. Clin Exp Immunol. 2008; 155(3):514-22. PMC: 2669528. DOI: 10.1111/j.1365-2249.2008.03843.x. View

3.
Cieslik M, Czapski G, Strosznajder J . The Molecular Mechanism of Amyloid β42 Peptide Toxicity: The Role of Sphingosine Kinase-1 and Mitochondrial Sirtuins. PLoS One. 2015; 10(9):e0137193. PMC: 4567180. DOI: 10.1371/journal.pone.0137193. View

4.
Evans C, Wisen S, Gestwicki J . Heat shock proteins 70 and 90 inhibit early stages of amyloid beta-(1-42) aggregation in vitro. J Biol Chem. 2006; 281(44):33182-91. DOI: 10.1074/jbc.M606192200. View

5.
Su J, Anderson A, Cribbs D, Tu C, Tong L, Kesslack P . Fas and Fas ligand are associated with neuritic degeneration in the AD brain and participate in beta-amyloid-induced neuronal death. Neurobiol Dis. 2003; 12(3):182-93. DOI: 10.1016/s0969-9961(02)00019-0. View